These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12699242)

  • 1. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients.
    Cruz-Rojo J; Fontanellas A; Morán-Jiménez MJ; Navarro-Ordóñez S; García-Bravo M; Méndez M; Muñoz-Rivero MC; de Salamanca RE
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):845-52. PubMed ID: 12699242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
    Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.
    Hift RJ; Corrigall AV; Hancock V; Kannemeyer J; Kirsch RE; Meissner PN
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies.
    Aarsand AK; Boman H; Sandberg S
    Clin Chem; 2009 Apr; 55(4):795-803. PubMed ID: 19233912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
    Egger NG; Goeger DE; Payne DA; Miskovsky EP; Weinman SA; Anderson KE
    Dig Dis Sci; 2002 Feb; 47(2):419-26. PubMed ID: 11855561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population.
    Méndez M; Rossetti MV; Del C Batlle AM; Parera VE
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):417-24. PubMed ID: 15761419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
    Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
    An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.
    Weiss Y; Chen B; Yasuda M; Nazarenko I; Anderson KE; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):363-366. PubMed ID: 30514647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
    Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
    J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.
    Méndez M; Poblete-Gutiérrez P; García-Bravo M; Wiederholt T; Morán-Jiménez MJ; Merk HF; Garrido-Astray MC; Frank J; Fontanellas A; Enríquez de Salamanca R
    Br J Dermatol; 2007 Sep; 157(3):501-7. PubMed ID: 17627795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
    Brady JJ; Jackson HA; Roberts AG; Morgan RR; Whatley SD; Rowlands GL; Darby C; Shudell E; Watson R; Paiker J; Worwood MW; Elder GH
    J Invest Dermatol; 2000 Nov; 115(5):868-74. PubMed ID: 11069625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
    Wolff CF; Armas RM; Frank J; Poblete PG
    Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
    Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW
    Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
    Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
    Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Porphyria cutanea tarda. An analysis of HFE gene mutations, hepatitis viruses, alcohol intake, and other risk factors in 54 patients from Guipúzcoa, Basque Country, Spain].
    Castiella A; Zapata E; de Juan MD; Múgica F; Barrio J; Otazua P; Arriola JA; Cosme A; Elosegui E; Fernández J; Zubiaurre L; Alzate LF; Utrilla E;
    Rev Esp Enferm Dig; 2008 Dec; 100(12):774-8. PubMed ID: 19222337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.
    Nagy Z; Kószó F; Pár A; Emri G; Horkay I; Horányi M; Karádi O; Rumi G; Morvay M; Varga V; Dobozy A; Mózsik G
    Liver Int; 2004 Feb; 24(1):16-20. PubMed ID: 15101996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation.
    Gómez-Abecia S; Morán-Jiménez MJ; Ruiz-Casares E; Henriques-Gil N; García-Pastor I; Garrido-Astray MC; Enríquez de Salamanca R; Méndez M
    Gene; 2013 Jun; 522(1):89-95. PubMed ID: 23545314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic porphyria cutanea tarda due to haemochromatosis.
    de Geus HR; Dees A
    Neth J Med; 2006 Sep; 64(8):307-9. PubMed ID: 16990695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.